Premium
Fluorescence Lifetime Spectroscopy of Glioblastoma Multiforme ¶
Author(s) -
Marcu Laura,
Jo Javier A.,
Butte Pramod V.,
Yong William H.,
Pikul Brian K.,
Black Keith L.,
Thompson Reid C.
Publication year - 2004
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.2004.tb00055.x
Subject(s) - fluorescence , glioblastoma , brain tumor , spectroscopy , fluorescence spectroscopy , laser , emission spectrum , brain tissue , glioma , laser induced fluorescence , time resolved spectroscopy , materials science , nuclear magnetic resonance , analytical chemistry (journal) , chemistry , spectral line , pathology , optics , medicine , biomedical engineering , cancer research , physics , quantum mechanics , astronomy , chromatography
Fluorescence spectroscopy of the endogenous emission of brain tumors has been researched as a potentially important method for the intraoperative localization of brain tumor margins. We investigated the use of time‐resolved, laser‐induced fluorescence spectroscopy for demarcation of primary brain tumors by studying the time‐resolved spectra of gliomas. The fluorescence of human brain samples (glioblastoma multiforme, cortex and white matter: six patients, 23 sites) was induced ex vivo with a pulsed nitrogen laser (337 nm, 3 ns). The time‐resolved spectra were detected in a 360–550 nm wavelength range using a fast digitizer and gated detection. Parameters derived from both the spectral‐ (intensities from narrow spectral bands) and the time domain (average lifetime) measured at 390 and 460 nm were used for tissue characterization. We determined that high‐grade gliomas are characterized by fluorescence lifetimes that varied with the emission wavelength (>3 ns at 390 nm, <1 ns at 460 nm) and their emission is overall longer than that of normal brain tissue. Our study demonstrates that the use of fluorescence lifetime not only improves the specificity of fluorescence measurements but also allows a more robust evaluation of data collected from brain tissue. Combined information from both the spectraland the time domain can enhance the ability of fluorescencebased techniques to diagnose and detect brain tumor margins intraoperatively.